CD8A and tuberculosis: In addition, changes in the mannosylation pattern of the M. bovis BCG Apa have been shown to alter its ability to stimulate CD4+ and CD8+ T-lymphocyte responses involved in the protective properties of the BCG vaccine against tuberculosis [70,71,72].